As a tumour suppressor, CDKN2A encodes 2 proteins that participate in two pivotal cell cycle regulatory pathways: the p53 pathway and RB pathway, and in our study, we focused on the contribution of altered RB gene set in ccRCC. The gene discussed is CDKN2A; the disease is nonpapillary renal cell carcinoma.